{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:21:36Z","timestamp":1793154096132,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK124211"],"award-info":[{"award-number":["DK124211"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007914","name":"University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["DP2HL163810"],"award-info":[{"award-number":["DP2HL163810"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["20POST35050060"],"award-info":[{"award-number":["20POST35050060"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["17POST32810003"],"award-info":[{"award-number":["17POST32810003"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jbc.2025.110594","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:23:55Z","timestamp":1755127435000},"page":"110594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-5530","authenticated-orcid":false,"given":"Xun","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6354-3588","authenticated-orcid":false,"given":"Rose","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Jane","family":"Dyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Saelices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1368-0223","authenticated-orcid":false,"given":"Peter E.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110594_bib1","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110594_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110594_bib4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.jbc.2025.110594_bib5","doi-asserted-by":"crossref","first-page":"E6741","DOI":"10.1073\/pnas.1805131115","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Saelices","year":"2018","journal-title":"P Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110594_bib6","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1074\/jbc.RA118.005257","article-title":"A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils","volume":"294","author":"Saelices","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110594_bib7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jacbts.2024.05.013","article-title":"Structure-based probe reveals the presence of large transthyretin aggregates in plasma of ATTR amyloidosis patients","volume":"9","author":"Pedretti","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.jbc.2025.110594_bib8","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1021\/bi011194d","article-title":"An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured","volume":"40","author":"Jiang","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41467-024-44820-3","article-title":"Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy","volume":"15","author":"Nguyen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110594_bib10","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.str.2024.09.021","article-title":"ATTRv-V30M amyloid fibrils from heart and nerves exhibit structural homogeneity","volume":"32","author":"Nguyen","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.jbc.2025.110594_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890","article-title":"Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes","volume":"8","author":"Maurer","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.jbc.2025.110594_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00415-016-8337-3","article-title":"Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study","volume":"264","author":"Plante-Bordeneuve","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jbc.2025.110594_bib13","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110594_bib14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.123.067225","article-title":"Detection of circulating transthyretin amyloid aggregates in plasma: a novel biomarker for transthyretin amyloidosis","volume":"149","author":"Pedretti","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jbc.2025.110594_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses","volume":"38","author":"Johnson","year":"2005","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jbc.2025.110594_bib16","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1021\/acs.biochem.8b01046","article-title":"Mispacking of the F87 side chain reduces the kinetic stability of human transthyretin","volume":"57","author":"Sun","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib17","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis","volume":"47","author":"Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib18","doi-asserted-by":"crossref","first-page":"E6201","DOI":"10.1073\/pnas.1807024115","article-title":"Kinetic analysis of the multi-step aggregation pathway of human transthyretin","volume":"115","author":"Sun","year":"2018","journal-title":"P Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110594_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168673","article-title":"Conformational dynamics of an amyloidogenic intermediate of transthyretin: implications for structural remodeling and amyloid formation","volume":"436","author":"Leach","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110594_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102162","article-title":"A transthyretin monomeric intermediate undergoes local unfolding and transient interaction with oligomers in a kinetically concerted aggregation pathway","volume":"298","author":"Sun","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110594_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jmb.2013.01.008","article-title":"Localized structural fluctuations promote amyloidogenic conformations in transthyretin","volume":"425","author":"Lim","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110594_bib22","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acs.biochem.6b00164","article-title":"Structural changes associated with transthyretin misfolding and amyloid formation revealed by solution and solid-state NMR","volume":"55","author":"Lim","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib23","doi-asserted-by":"crossref","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","article-title":"Mechanisms of transthyretin inhibition of beta-amyloid aggregation in vitro","volume":"33","author":"Li","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110594_bib24","doi-asserted-by":"crossref","DOI":"10.1021\/acs.biochem.0c00091","article-title":"Structural characterization of cardiac ex vivo transthyretin amyloid: insight into transthyretin misfolding pathway in vivo","author":"Dasari","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41598-018-37230-1","article-title":"Transthyretin aggregation pathway toward the formation of distinct cytotoxic oligomers","volume":"9","author":"Dasari","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110594_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/srep11443","article-title":"Considerably unfolded transthyretin monomers preceed and exchange with dynamically structured amyloid protofibrils","volume":"5","author":"Groenning","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110594_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","article-title":"Dependence of alpha-synuclein aggregate morphology on solution conditions","volume":"322","author":"Hoyer","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110594_bib28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.peptides.2009.04.012","article-title":"Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects","volume":"30","author":"Sun","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.jbc.2025.110594_bib29","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1021\/jacs.1c04786","article-title":"Quantitative exchange NMR-based analysis of Huntingtin-SH3 interactions suggests an allosteric mechanism of inhibition of huntingtin aggregation","volume":"143","author":"Ceccon","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110594_bib30","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.1021\/jacs.4c16743","article-title":"Kinetic steering of amyloid formation and polymorphism by canagliflozin, a Type-2 diabetes drug","volume":"147","author":"Taylor","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110594_bib31","doi-asserted-by":"crossref","first-page":"24251","DOI":"10.1073\/pnas.2006684117","article-title":"Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors","volume":"117","author":"Michaels","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110594_bib32","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1021\/acs.biochem.7b00815","article-title":"Fluorotryptophan incorporation modulates the structure and stability of transthyretin in a site-specific manner","volume":"56","author":"Sun","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2025.110594_bib33","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1021\/acs.jmedchem.9b01037","article-title":"Binding of monovalent and bivalent ligands by transthyretin causes different Short- and long-distance conformational changes","volume":"62","author":"Corazza","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825024457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825024457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:54:51Z","timestamp":1773132891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825024457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0021925825024457"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110594","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of inhibition of acid-mediated transthyretin aggregation by designed peptides","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110594"}}